FR2924613B1 - Utilisation cosmetique de proteines de type hsp27. - Google Patents

Utilisation cosmetique de proteines de type hsp27.

Info

Publication number
FR2924613B1
FR2924613B1 FR0759679A FR0759679A FR2924613B1 FR 2924613 B1 FR2924613 B1 FR 2924613B1 FR 0759679 A FR0759679 A FR 0759679A FR 0759679 A FR0759679 A FR 0759679A FR 2924613 B1 FR2924613 B1 FR 2924613B1
Authority
FR
France
Prior art keywords
hsp27
proteins
type
cosmetic use
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0759679A
Other languages
English (en)
Other versions
FR2924613A1 (fr
Inventor
Dominique Bernard
Lucie Simonetti
Isabelle Castiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0759679A priority Critical patent/FR2924613B1/fr
Publication of FR2924613A1 publication Critical patent/FR2924613A1/fr
Application granted granted Critical
Publication of FR2924613B1 publication Critical patent/FR2924613B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0759679A 2007-12-10 2007-12-10 Utilisation cosmetique de proteines de type hsp27. Expired - Fee Related FR2924613B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0759679A FR2924613B1 (fr) 2007-12-10 2007-12-10 Utilisation cosmetique de proteines de type hsp27.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0759679A FR2924613B1 (fr) 2007-12-10 2007-12-10 Utilisation cosmetique de proteines de type hsp27.

Publications (2)

Publication Number Publication Date
FR2924613A1 FR2924613A1 (fr) 2009-06-12
FR2924613B1 true FR2924613B1 (fr) 2012-12-21

Family

ID=39529669

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0759679A Expired - Fee Related FR2924613B1 (fr) 2007-12-10 2007-12-10 Utilisation cosmetique de proteines de type hsp27.

Country Status (1)

Country Link
FR (1) FR2924613B1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750674B2 (en) 2010-06-11 2017-09-05 The Procter & Gamble Company Compositions for treating skin
US10085924B2 (en) 2014-11-10 2018-10-02 The Procter & Gamble Company Personal care compositions
US10942107B2 (en) 2017-12-08 2021-03-09 The Procter & Gamble Company Methods of screening for mild skin cleanser
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US10987290B2 (en) 2017-10-20 2021-04-27 The Procter And Gamble Company Aerosol foam skin cleanser
US11207261B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US11365397B2 (en) 2018-11-29 2022-06-21 The Procter & Gamble Company Methods for screening personal care products
US11419805B2 (en) 2017-10-20 2022-08-23 The Procter & Gamble Company Aerosol foam skin cleanser

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2405888B1 (fr) * 2009-03-10 2018-04-11 Alfa Biogene International B.V. Produit de soins cutanés
CN102465182A (zh) * 2010-10-29 2012-05-23 株式会社爱茉莉太平洋 检测皮肤活性物质的检测试剂盒和检测皮肤活性物质的方法
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2758984B1 (fr) * 1997-02-03 1999-04-16 Serobiologiques Lab Sa Complexe synergique actif et produit cosmetique et/ou pharmaceutique comprenant ce complexe
EP1166765A3 (fr) * 2000-06-20 2002-05-02 Laboratoires Serobiologiques Procédé pour protéger la peau humaine
DE10100122A1 (de) * 2001-01-03 2002-07-11 Henkel Kgaa Verfahren zur Bestimmung der Hautalterung in vitro
DE10245988B4 (de) * 2002-10-01 2005-01-27 Dr. André Rieks, Labor für Enzymtechnologie GmbH Neue Curcumin-Derivate für den Einsatz in Kosmetika, Pharmazeutika und bei der Ernährung
FR2847467B1 (fr) * 2002-11-25 2006-05-26 Oreal UTILISATION D'UN AGENT MODULATEUR DE L'ACTIVITE DE L'OXYSTEROL 7alpha-HYDROXYLASE POUR LE TRAITEMENT COSMETIQUE DE DESORDRES CUTANES
FR2865647B1 (fr) * 2004-02-02 2006-04-07 Silab Sa Activites d'un principe actif obtenu a partir de poudre de semences d'alfalfa (medicago sativa), principe actif utilise et peocede d'obtention
JP4815752B2 (ja) * 2004-04-01 2011-11-16 味の素株式会社 アミノ酸含有飲食品
FR2877220B1 (fr) * 2004-11-04 2008-10-10 Oreal Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
US7927614B2 (en) * 2006-02-03 2011-04-19 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750674B2 (en) 2010-06-11 2017-09-05 The Procter & Gamble Company Compositions for treating skin
US10588838B2 (en) 2010-06-11 2020-03-17 The Procter & Gamble Company Compositions for treating skin
US10085924B2 (en) 2014-11-10 2018-10-02 The Procter & Gamble Company Personal care compositions
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US11207261B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US10987290B2 (en) 2017-10-20 2021-04-27 The Procter And Gamble Company Aerosol foam skin cleanser
US11419805B2 (en) 2017-10-20 2022-08-23 The Procter & Gamble Company Aerosol foam skin cleanser
US10942107B2 (en) 2017-12-08 2021-03-09 The Procter & Gamble Company Methods of screening for mild skin cleanser
US11365397B2 (en) 2018-11-29 2022-06-21 The Procter & Gamble Company Methods for screening personal care products

Also Published As

Publication number Publication date
FR2924613A1 (fr) 2009-06-12

Similar Documents

Publication Publication Date Title
FR2924613B1 (fr) Utilisation cosmetique de proteines de type hsp27.
FR2925312B1 (fr) Utilisation cosmetique de proteines de type desmogleine i
FR2917629B1 (fr) Utilisation cosmetique de proteines de type apolipoproteine d
FR2924614B1 (fr) Utilisation cosmetique de proteines de type calgranuline a.
ATE544443T1 (de) Haarpflegezusammensetzung
DK3118220T3 (da) Protein
BRPI0914155A2 (pt) preparações de xampu
FR2924946B1 (fr) Utilisation cosmetique de proteines de type ceramidase acide
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
DE502007001405D1 (de) Haarpflegezusammensetzung
BRPI0811637A2 (pt) Proteínas de fusão da imunoglobina
BRPI0810153A2 (pt) Eixo de pivô de cartucho de aparelho de barbear ou depilar
UA17897S (uk) Губка косметична
BRPI0917027A2 (pt) composição de condicionador de cabelo
ATE543407T1 (de) Kosmetikbehälter
BRPI0814971A2 (pt) Proteína
DK1856494T3 (da) Hårfarvningssystem
FR2918569B1 (fr) Substances inhibant la glycation des proteines.
DE602005022364D1 (de) Selbstbräunendes kosmetikum
BRPI0914152A2 (pt) preparações de xampu
BRPI1014898A2 (pt) cosmético capilar.
FR2924947B1 (fr) Utilisation cosmetique de proteines de type calmodulin-like skin protein clsp
BRPI0910019A2 (pt) composição cosmética
FR2925314B1 (fr) Utilisation cosmetique de proteines de type transglutaminase 3
FR2899103B1 (fr) Utilisation cosmetique de d-ribose

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13

ST Notification of lapse

Effective date: 20210806